Showing 20 of 162 recruiting trials for “nasopharyngeal-carcinoma”
Adaptive Neoadjuvant Therapy for Esophageal Cancer
👨⚕️ Tao Zhen Yu, MD, National Cancer Center/ Cancer Hospital &Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College📍 1 site📅 Started Mar 2028View details ↗
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
👨⚕️ Matin Imanguli, JHU Sidney Kimmel Comprehensive Cancer Center LAO📍 3 sites📅 Started Aug 2026View details ↗
RecruitingNCT07464470 ↗
Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers
👨⚕️ Alexey Tryakin, MD, PhD, professor, Blokhin's Russian Cancer Research Center📍 1 site📅 Started Apr 2026View details ↗
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ yuecan zeng, doctor, The Second Affiliated Hospital of Hainan Medical University📍 1 site📅 Started Feb 2026View details ↗
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
👨⚕️ Jiang D Sui, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07376603 ↗
IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
RecruitingNCT07232680 ↗
Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
👨⚕️ Rodney Cheng En Hsieh, MD, PhD, Chang Gung Memorial Hospital📍 1 site📅 Started Nov 2025View details ↗
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial
Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma
Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
Page 1 of 9Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →